didodecyldimethylammonium has been researched along with tobramycin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joyce, P; Prestidge, CA; Subramaniam, S | 1 |
1 other study(ies) available for didodecyldimethylammonium and tobramycin
| Article | Year |
|---|---|
Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2023 |